Convalescent Plasma as Treatment for Hospitalized Subjects With COVID-19 Infection
NCT04343755
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
52
Enrollment
OTHER
Sponsor class
Stopped
Lack of eligible patients due to change in standard therapy
Conditions
COVID-19
Interventions
BIOLOGICAL:
Convalescent Plasma
Sponsor
Hackensack Meridian Health